Ignite Creation Date:
2025-12-24 @ 11:14 PM
Ignite Modification Date:
2026-01-05 @ 10:52 PM
Study NCT ID:
NCT02971969
Status:
COMPLETED
Last Update Posted:
2022-01-06
First Post:
2016-11-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Long-Term Safety, Tolerability, and Efficacy of DTX101 (AAVrh10FIX) in Adults With Moderate/Severe to Severe Hemophilia B
Sponsor:
Ultragenyx Pharmaceutical Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-01
Start Date Type:
None
Primary Completion Date:
2021-11-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-11-06
Completion Date Type:
ACTUAL
First Submit Date:
2016-11-21
First Submit QC Date:
None
Study First Post Date:
2016-11-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-01-04
Last Update Post Date:
2022-01-06
Last Update Post Date Type:
ACTUAL